Regulation of System xc- by Interleukin-1 beta

Interleukin-1 beta 对 xc- 系统的调节

基本信息

项目摘要

DESCRIPTION (provided by applicant): Oxidative stress is a harmful condition that occurs when an imbalance between the production of reactive oxygen species (ROS) and the cellular defenses utilized to neutralize the toxic intermediates exists such that equilibrium is shifted in favor of ROS. Oxidative stress is involved in normal aging and a variety of diseases of the aged including Alzheimer's and Parkinson's disease and stroke. Recently, our laboratory has demonstrated in mixed cortical cell cultures that the cytokine interleukin-1beta (IL-1beta ) - which is upregulated in numerous neurological diseases/disorders - enhances the activity of the amino acid transporter system xc mediating an increase in cellular cyst(e)ine, a constituent of the tripeptide antioxidant molecule glutathione. Thus, the objective of this proposal is to elucidate the cellular, molecular, and biochemical mechanisms by which IL-1beta regulates system xc. In Aim 1, studies will identify the cell type or types in which the transporter is regulated. Using pure neuronal and astrocyte cultures and chimeric mixed cultures containing a combination of wild-type and system xc deficient cells, the specific hypothesis that IL-1beta enhances the activity of astrocytic system xc will be tested. Using numerous models of oxidative stress, the functional significance of this increase in activity will also be ascertained. In Aim 2, experiments will be performed to determine the mechanism by which IL-1beta regulates system xc. State of the art molecular biological approaches will be utilized to assess whether regulation occurs at the transcriptional and/or post-transcriptional level. Overall, the long-term objective of this project is to better understand how IL-1beta regulates the cystine-glutamate (system xc) transporter. A greater understanding of its regulation may enable researchers to target therapies to increase intracellular glutathione levels for the reduction of oxidative injury. PUBLIC HEALTH RELEVANCE: Oxidative stress is a harmful condition involved in both normal aging and a variety of neurological diseases/disorders of the aged. Strategies aimed at limiting and repairing the damage attributed to oxidative stress may slow the advance of many age-related diseases. Successful completion of this proposal will advance and refine our knowledge about an important new therapeutic target (system xc-) that complements other ongoing efforts to reduce injury associated with oxidative stress.
描述(由申请人提供):氧化应激是一种有害的疾病,当活性氧(ROS)的产生与用于中和有毒中间体的细胞防御之间存在不平衡时,会发生这种情况,从而使平衡向有利于ROS的方向移动。氧化应激与正常衰老和多种老年疾病有关,包括阿尔茨海默氏病、帕金森氏病和中风。最近,我们的实验室已经证明,在混合的皮质细胞培养的细胞因子白细胞介素-1 β(IL-1 β)-这是上调在许多神经系统疾病/障碍-增强的活动,氨基酸转运系统xc介导的细胞内胱氨酸,三肽抗氧化剂分子谷胱甘肽的成分增加。因此,本研究的目的是阐明IL-1 β调节xc系统的细胞、分子和生化机制。在目标1中,研究将确定转运蛋白受调控的细胞类型。使用纯神经元和星形胶质细胞培养物以及含有野生型和系统xc缺陷细胞组合的嵌合混合培养物,将测试IL-1 β增强星形胶质细胞系统xc活性的特定假设。使用氧化应激的许多模型,这种活性增加的功能意义也将被确定。在目标2中,将进行实验以确定IL-1 β调节系统xc的机制。将利用最先进的分子生物学方法来评估调控是否发生在转录和/或转录后水平。总体而言,该项目的长期目标是更好地了解IL-1 β如何调节胱氨酸-谷氨酸(系统xc)转运蛋白。对其调节的更深入了解可能使研究人员能够靶向治疗以增加细胞内谷胱甘肽水平以减少氧化损伤。 公共卫生关系:氧化应激是一种与正常衰老和老年人的各种神经系统疾病/障碍有关的有害状况。旨在限制和修复氧化应激损伤的策略可能会减缓许多与年龄相关的疾病的进展。这项提案的成功完成将推进和完善我们对一个重要的新的治疗靶点(系统xc-)的认识,补充其他正在进行的努力,以减少与氧化应激相关的损伤。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nicole Alyse Jackman其他文献

Nicole Alyse Jackman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nicole Alyse Jackman', 18)}}的其他基金

Regulation of System xc- by Interleukin-1 beta
Interleukin-1 beta 对 xc- 系统的调节
  • 批准号:
    7773205
  • 财政年份:
    2009
  • 资助金额:
    $ 5.46万
  • 项目类别:

相似国自然基金

新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 批准年份:
    2010
  • 资助金额:
    26.0 万元
  • 项目类别:
    地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
  • 批准号:
    30960334
  • 批准年份:
    2009
  • 资助金额:
    22.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
  • 批准号:
    10657993
  • 财政年份:
    2023
  • 资助金额:
    $ 5.46万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10381163
  • 财政年份:
    2022
  • 资助金额:
    $ 5.46万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10531959
  • 财政年份:
    2022
  • 资助金额:
    $ 5.46万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10700991
  • 财政年份:
    2022
  • 资助金额:
    $ 5.46万
  • 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10518582
  • 财政年份:
    2022
  • 资助金额:
    $ 5.46万
  • 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10672973
  • 财政年份:
    2022
  • 资助金额:
    $ 5.46万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10585925
  • 财政年份:
    2022
  • 资助金额:
    $ 5.46万
  • 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
  • 批准号:
    10180000
  • 财政年份:
    2021
  • 资助金额:
    $ 5.46万
  • 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
  • 批准号:
    10049426
  • 财政年份:
    2021
  • 资助金额:
    $ 5.46万
  • 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
  • 批准号:
    10295809
  • 财政年份:
    2021
  • 资助金额:
    $ 5.46万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了